Literature DB >> 9109387

Photoactivation of the nitric oxide donor SIN-1.

T Ullrich1, S Oberle, A Abate, H Schröder.   

Abstract

This study investigates whether nitric oxide (NO) release from linsidomine (SIN-1), the active metabolite of the antianginal drug molsidomine, is light sensitive. A 9-h irradiation with polychromatic visible light increased the formation of nitrite (NO index metabolite) from SIN-1 (1 mM) by 61% as compared to control samples incubated in the dark. Under the same conditions (9-h irradiation) the concentration of oxygen decreased to 2% of control. However, oxygen consumption was substantially reduced when light was excluded (35% recovery after 9 h). These results show that irradiation with visible light markedly enhances the oxygen-dependent NO release from SIN-1. Thus, sydnonimines appear to be suitable model compounds for the development of photoactivatable NO donors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9109387     DOI: 10.1016/s0014-5793(97)00239-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  5 in total

1.  The nitric oxide donor SIN-1 is free of tolerance and maintains its cyclic GMP stimulatory potency in nitrate-tolerant LLC-PK1 cells.

Authors:  B Hinz; H Schröder
Journal:  Pharm Res       Date:  1999-05       Impact factor: 4.200

Review 2.  Analytical chemistry of nitric oxide.

Authors:  Evan M Hetrick; Mark H Schoenfisch
Journal:  Annu Rev Anal Chem (Palo Alto Calif)       Date:  2009       Impact factor: 10.745

Review 3.  Opportunities for Nitric Oxide in Potentiating Cancer Immunotherapy.

Authors:  Jihoon Kim; Susan N Thomas
Journal:  Pharmacol Rev       Date:  2022-10       Impact factor: 18.923

4.  Decomposition mechanism of 3-N-morpholinosydnonimine (SIN-1)--a density functional study on intrinsic structures and reactivities.

Authors:  Roy U Rojas Wahl
Journal:  J Mol Model       Date:  2004-03-02       Impact factor: 1.810

5.  Cellular and subcellular oxidative stress parameters following severe spinal cord injury.

Authors:  Nishant P Visavadiya; Samir P Patel; Jenna L VanRooyen; Patrick G Sullivan; Alexander G Rabchevsky
Journal:  Redox Biol       Date:  2015-12-30       Impact factor: 11.799

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.